Coding Strategy:
Doctor Prescribing Venetoclax for CLL Patients? Here's What to Submit
Published on Mon Nov 14, 2016
Keep documentation for patient selection and any prior treatment. Have you been coding accurately for venetoclax? On April 11, 2016, the FDA approved venetoclax (Venclexta; Janssen) tablets for the treatment of patients of chronic lymphocytic leukemia (CLL) with depletion of 17p chromosome. When to use venetoclax: Your physician will prescribe venetoclax when: The detection of chromosome 17p deletion is established [...]